Table of Contents
The Brown University Psychopharmacology Update · 2007
DOI: 10.1002/pu.20055 ↗Abstrakt
Abstract Drug Targeting Glutamate Receptors Shows Promise for Schizophrenia Treatment GRIK4, HTR2A Markers Indicate Reduced Risk of Nonresponse to Citalopram Meropenem may Increase Concentration of Valproate Piracetam Reduces TD Symptoms Lithium may Protect Against TD Why Patients Fail to Take their Psychotropics Antidepressants may Worsen Bipolar Mania Obesity Affects Depression Treatment Response Brugada Syndrome in a Patient Receiving Lithium Approval: Risperdal for Adolescents
EUVIMED